Biggest Stock Market Losers (VRNG, LEI, CTIC, FSLR)

Los Angelas, CA -- (SBWIRE) -- 10/08/2012 -- Vringo, Inc. (VRNG) is a development-stage company. The Company is engaged in developing software for mobile phones. It provides a platform, which allows users to create, download and share mobile entertainment content in the form of video ringtones for mobile phones. Vringo, Inc. (NYSEAMEX: VRNG) shares had an amazing run up this week and soared almost 58% past week and made a time high of $5.55 in Thursday’s session ahead of the trial this week. However , On Friday the stock fell 13.50% after it has raised $45 million in a bid to boost its balance sheet size.

Are these stocks a buy or sell? Let us help you decide, Check here

Lucas Energy, Inc. (NYSEAMEX:LEI) is an independent oil and gas company based in Houston, Texas with approximately 12,500 gross acres (10,400 acres net) of oil and gas leases in South Texas primarily in the Gonzales County and Wilson County, Texas. The Company is engaged in the exploration and production of oil and natural gas. It holds oil and gas interests in the Austin Chalk formation, Buda formation and Eagle Ford Shale formation. As of March 31, 2010, Lucas operated 30 wells that produced approximately 190-200 barrels of oil per day (BOPD) gross. During the fiscal year ended March 31, 2010 (fiscal 2010), its oil production sales totaled 27,833 barrel oil equivalent.Lucas Energy, Inc (AMEX:LEI) is -0.21 - -9.38% from the previous close of $2.24. It traded between $1.83 - 2.23 with total traded volume of 1054009 shares. Keep a close eye onLEI, as the stock has been showing unusual moves over the past weeks. At Current market price, LEI has recovered +62.40% from its 52-week Low of 1.25 and has Pulled back -37.35% from its 52-week high of 3.24.

Can LEI Find The Bottom or further move to top? Find Out Here

Shares of Cell Therapeutics (NASDAQ: CTIC) are trading at $1.5316 and is -36.36% of its 50-day Moving Average price of $2.4066 and -59.85% from its 200-day Moving Average price of $3.8145. The average trading volume is 1785510 shares and its market capitalization is $65.1M.Cell Therapeutics (NASDAQ:CTIC) lost a quarter of their value on the day, subsequent to the pricing of its offering of 60,000 shares of convertible preferred stock. Each share is convertible into approximately 714 shares of common stock at $1.40, representing about 42.9 million shares. Currently, the outstanding float is 52.25 million shares.

How Should Investors React To CTIC Now? Find Here

Rising manufacturing capacity of solar panels and wind turbines in China has made a large oversupply and a possible financial crisis for manufacturers such as First Solar, Inc. (NASDAQ:FSLR) and state-owned banks, according to the New York Times. China’s most prominent solar panel makers have faced losses of as much as $1 for every $3 of sales during the year.First Solar, Inc. (NasdaqNM:FSLR) reported EPS of -6.414. For the Current Fiscal year, the company is expected to report EPS of 4.44. For the Next Quarter and Next Year, the company is expected to report EPS of 1.85 and 3.96 respectively. At Current Market Price, FSLR is in distance of -9.63% from its 50-day Moving Average price of $22.2097 and +7.83% from its 200-day Moving Average price of $18.612.

Will FSLR Shareholders Sell on Bad Sector News? Free Sign Up Here

DISCLAIMER:

Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com